Venetoclax improves CD20 immunotherapy in a mouse model of MYC/BCL2 double-expressor diffuse large B-cell lymphoma.
Melchor J, Garcia-Lacarte M, Grijalba SC, Arnaiz-Leché A, Pascual M, Panizo C, Blanco O, Segura V, Novo FJ, Valero JG, Pérez-Galán P, Martinez-Climent JA, Roa S.
Melchor J, et al. Among authors: novo fj.
J Immunother Cancer. 2023 Feb;11(2):e006113. doi: 10.1136/jitc-2022-006113.
J Immunother Cancer. 2023.
PMID: 36854569
Free PMC article.